US6273913B1
(en)
|
1997-04-18 |
2001-08-14 |
Cordis Corporation |
Modified stent useful for delivery of drugs along stent strut
|
US20030129215A1
(en)
*
|
1998-09-24 |
2003-07-10 |
T-Ram, Inc. |
Medical devices containing rapamycin analogs
|
US7399480B2
(en)
|
1997-09-26 |
2008-07-15 |
Abbott Laboratories |
Methods of administering tetrazole-containing rapamycin analogs with other therapeutic substances using medical devices
|
US6890546B2
(en)
|
1998-09-24 |
2005-05-10 |
Abbott Laboratories |
Medical devices containing rapamycin analogs
|
US7208010B2
(en)
|
2000-10-16 |
2007-04-24 |
Conor Medsystems, Inc. |
Expandable medical device for delivery of beneficial agent
|
US6241762B1
(en)
|
1998-03-30 |
2001-06-05 |
Conor Medsystems, Inc. |
Expandable medical device with ductile hinges
|
US7713297B2
(en)
*
|
1998-04-11 |
2010-05-11 |
Boston Scientific Scimed, Inc. |
Drug-releasing stent with ceramic-containing layer
|
US20060240070A1
(en)
*
|
1998-09-24 |
2006-10-26 |
Cromack Keith R |
Delivery of highly lipophilic agents via medical devices
|
US7455853B2
(en)
|
1998-09-24 |
2008-11-25 |
Abbott Cardiovascular Systems Inc. |
Medical devices containing rapamycin analogs
|
EP1582180B1
(en)
|
2000-10-16 |
2008-02-27 |
Conor Medsystems, Inc. |
Expandable medical device for delivery of beneficial agent
|
US20050084514A1
(en)
*
|
2000-11-06 |
2005-04-21 |
Afmedica, Inc. |
Combination drug therapy for reducing scar tissue formation
|
US20030050692A1
(en)
*
|
2000-12-22 |
2003-03-13 |
Avantec Vascular Corporation |
Delivery of therapeutic capable agents
|
US20050125054A1
(en)
*
|
2000-12-22 |
2005-06-09 |
Avantec Vascular Corporation |
Devices delivering therapeutic agents and methods regarding the same
|
US20030033007A1
(en)
*
|
2000-12-22 |
2003-02-13 |
Avantec Vascular Corporation |
Methods and devices for delivery of therapeutic capable agents with variable release profile
|
US20020082679A1
(en)
*
|
2000-12-22 |
2002-06-27 |
Avantec Vascular Corporation |
Delivery or therapeutic capable agents
|
US7077859B2
(en)
*
|
2000-12-22 |
2006-07-18 |
Avantec Vascular Corporation |
Apparatus and methods for variably controlled substance delivery from implanted prostheses
|
US20050203612A1
(en)
*
|
2000-12-22 |
2005-09-15 |
Avantec Vascular Corporation |
Devices delivering therapeutic agents and methods regarding the same
|
GB0100761D0
(en)
|
2001-01-11 |
2001-02-21 |
Biocompatibles Ltd |
Drug delivery from stents
|
CN100469394C
(zh)
*
|
2001-02-16 |
2009-03-18 |
艾伯特实验室血管有限公司 |
具有fk506的植入体
|
US8182527B2
(en)
|
2001-05-07 |
2012-05-22 |
Cordis Corporation |
Heparin barrier coating for controlled drug release
|
US7842083B2
(en)
|
2001-08-20 |
2010-11-30 |
Innovational Holdings, Llc. |
Expandable medical device with improved spatial distribution
|
US20080145402A1
(en)
*
|
2001-09-10 |
2008-06-19 |
Abbott Cardiovascular Systems Inc. |
Medical Devices Containing Rapamycin Analogs
|
US7195640B2
(en)
*
|
2001-09-25 |
2007-03-27 |
Cordis Corporation |
Coated medical devices for the treatment of vulnerable plaque
|
US10441747B2
(en)
*
|
2002-01-22 |
2019-10-15 |
Mercator Medsystems, Inc. |
Methods and systems for inhibiting vascular inflammation
|
IL162734A0
(en)
|
2002-02-01 |
2005-11-20 |
Ariad Gene Therapeutics Inc |
Phosphorus-containing compounds & uses thereof
|
EP1485042A1
(en)
*
|
2002-03-18 |
2004-12-15 |
Medtronic AVE Inc. |
Medical devices for delivering anti-proliferative compositions to anatomical sites at risk of restenosis
|
US20040133270A1
(en)
*
|
2002-07-08 |
2004-07-08 |
Axel Grandt |
Drug eluting stent and methods of manufacture
|
US20050214343A1
(en)
*
|
2002-07-18 |
2005-09-29 |
Patrice Tremble |
Medical devices comprising a protein-tyrosine kinase inhibitor to inhibit restonosis
|
GB0219052D0
(en)
|
2002-08-15 |
2002-09-25 |
Cyclacel Ltd |
New puring derivatives
|
PL375698A1
(en)
*
|
2002-09-06 |
2005-12-12 |
Abbott Laboratories |
Medical device having hydration inhibitor
|
US9770349B2
(en)
*
|
2002-11-13 |
2017-09-26 |
University Of Virginia Patent Foundation |
Nanoporous stents with enhanced cellular adhesion and reduced neointimal formation
|
CA2516175A1
(en)
*
|
2003-02-18 |
2004-09-02 |
Medtronic, Inc. |
Occlusion resistant hydrocephalic shunt
|
AR043504A1
(es)
*
|
2003-03-17 |
2005-08-03 |
Novartis Ag |
Composiciones farmaceuticas que comprenden rapamicina para el tratamiento de enfermedades inflamatorias
|
US8088404B2
(en)
*
|
2003-03-20 |
2012-01-03 |
Medtronic Vasular, Inc. |
Biocompatible controlled release coatings for medical devices and related methods
|
US20040254629A1
(en)
*
|
2003-04-25 |
2004-12-16 |
Brian Fernandes |
Methods and apparatus for treatment of aneurysmal tissue
|
US20050033417A1
(en)
*
|
2003-07-31 |
2005-02-10 |
John Borges |
Coating for controlled release of a therapeutic agent
|
EP1656163B1
(en)
*
|
2003-08-13 |
2014-08-06 |
Poly-Med, Inc. |
Biocompatible controlled release coatings for medical devices and related methods
|
AR045957A1
(es)
*
|
2003-10-03 |
2005-11-16 |
Novartis Ag |
Composicion farmaceutica y combinacion
|
US7659244B2
(en)
|
2003-11-03 |
2010-02-09 |
Quest Pharmatech, Inc. |
Rapamycin peptides conjugates: synthesis and uses thereof
|
WO2005049021A1
(en)
*
|
2003-11-03 |
2005-06-02 |
Oy Helsinki Transplantation R & D Ltd |
Materials and methods for inhibiting neointimal hyperplasia
|
GB0327840D0
(en)
*
|
2003-12-01 |
2003-12-31 |
Novartis Ag |
Organic compounds
|
US7303758B2
(en)
*
|
2004-01-20 |
2007-12-04 |
Cordis Corporation |
Local vascular delivery of mycophenolic acid in combination with rapamycin to prevent restenosis following vascular injury
|
WO2005075003A1
(en)
*
|
2004-01-21 |
2005-08-18 |
Medtronic Vascular Inc. |
Implantable medical devices for treating or preventing restenosis
|
CA2552759A1
(en)
*
|
2004-01-22 |
2005-08-04 |
Novartis Ag |
Combination of organic compounds
|
US8431145B2
(en)
|
2004-03-19 |
2013-04-30 |
Abbott Laboratories |
Multiple drug delivery from a balloon and a prosthesis
|
US20070027523A1
(en)
*
|
2004-03-19 |
2007-02-01 |
Toner John L |
Method of treating vascular disease at a bifurcated vessel using coated balloon
|
US8551512B2
(en)
|
2004-03-22 |
2013-10-08 |
Advanced Cardiovascular Systems, Inc. |
Polyethylene glycol/poly(butylene terephthalate) copolymer coated devices including EVEROLIMUS
|
US8003122B2
(en)
*
|
2004-03-31 |
2011-08-23 |
Cordis Corporation |
Device for local and/or regional delivery employing liquid formulations of therapeutic agents
|
US7846940B2
(en)
*
|
2004-03-31 |
2010-12-07 |
Cordis Corporation |
Solution formulations of sirolimus and its analogs for CAD treatment
|
US20050220836A1
(en)
*
|
2004-03-31 |
2005-10-06 |
Robert Falotico |
Drug delivery device
|
US8778014B1
(en)
|
2004-03-31 |
2014-07-15 |
Advanced Cardiovascular Systems, Inc. |
Coatings for preventing balloon damage to polymer coated stents
|
US8163269B2
(en)
*
|
2004-04-05 |
2012-04-24 |
Carpenter Kenneth W |
Bioactive stents for type II diabetics and methods for use thereof
|
US8293890B2
(en)
|
2004-04-30 |
2012-10-23 |
Advanced Cardiovascular Systems, Inc. |
Hyaluronic acid based copolymers
|
MXPA06013294A
(es)
*
|
2004-05-17 |
2007-02-02 |
Novartis Ag |
Combinacion de compuestos organicos.
|
US20050287184A1
(en)
*
|
2004-06-29 |
2005-12-29 |
Hossainy Syed F A |
Drug-delivery stent formulations for restenosis and vulnerable plaque
|
WO2006020755A2
(en)
*
|
2004-08-10 |
2006-02-23 |
Beth Israel Deaconess Medical Center, Inc. |
Methods for identifying inhibitors of the mtor pathway as diabetes therapeutics
|
US20060051338A1
(en)
*
|
2004-08-20 |
2006-03-09 |
New York University |
Inhibition of mitogen-activated protein kinases in cardiovascular disease
|
WO2006053754A1
(en)
*
|
2004-11-19 |
2006-05-26 |
Novartis Ag |
COMBINATIONS OF ANTI-ATHEROSCLEROTIC PEPTIDES AND AN mTOR INHIBITING AGENT AND THEIR METHODS OF USE
|
US20090041778A1
(en)
*
|
2004-11-22 |
2009-02-12 |
Sukhatme Vikas P |
Methods And Compositions For The Treatment Of Graft Failure
|
US20060127443A1
(en)
*
|
2004-12-09 |
2006-06-15 |
Helmus Michael N |
Medical devices having vapor deposited nanoporous coatings for controlled therapeutic agent delivery
|
US20060129215A1
(en)
*
|
2004-12-09 |
2006-06-15 |
Helmus Michael N |
Medical devices having nanostructured regions for controlled tissue biocompatibility and drug delivery
|
US20060204546A1
(en)
*
|
2005-03-14 |
2006-09-14 |
Conor Medsystems, Inc. |
Methods and systems for delivering immunosuppressant and anti-inflammatory agents from a stent
|
JP5271697B2
(ja)
*
|
2005-03-23 |
2013-08-21 |
アボット ラボラトリーズ |
医療装置を介する高親油性薬剤の送達
|
US7252834B2
(en)
|
2005-04-25 |
2007-08-07 |
Clemson University Research Foundation (Curf) |
Elastin stabilization of connective tissue
|
BRPI0611021A2
(pt)
*
|
2005-05-31 |
2010-08-10 |
Novartis Ag |
combinação de inibidores de hmg-coa redutase e inibidores de mtor
|
US20070009564A1
(en)
*
|
2005-06-22 |
2007-01-11 |
Mcclain James B |
Drug/polymer composite materials and methods of making the same
|
US20070038176A1
(en)
*
|
2005-07-05 |
2007-02-15 |
Jan Weber |
Medical devices with machined layers for controlled communications with underlying regions
|
WO2007011708A2
(en)
|
2005-07-15 |
2007-01-25 |
Micell Technologies, Inc. |
Stent with polymer coating containing amorphous rapamycin
|
WO2007011707A2
(en)
|
2005-07-15 |
2007-01-25 |
Micell Technologies, Inc. |
Polymer coatings containing drug powder of controlled morphology
|
WO2007053578A2
(en)
*
|
2005-10-31 |
2007-05-10 |
Amulet Pharmaceuticals, Inc. |
Multi-phasic nitric oxide and drug co-eluting stent coatings
|
US20070116736A1
(en)
*
|
2005-11-23 |
2007-05-24 |
Argentieri Dennis C |
Local vascular delivery of PI3 kinase inhibitors alone or in combination with sirolimus to prevent restinosis following vascular injury
|
US20070196327A1
(en)
*
|
2005-12-06 |
2007-08-23 |
Amulet Pharmaceuticals, Inc. |
Nitric oxide releasing polymers
|
US20070203171A1
(en)
*
|
2006-02-28 |
2007-08-30 |
Zhao Jonathon Z |
Combination of rapamycin and its tetrazole isomers and epimers, methods of making and using the same
|
US20070224235A1
(en)
*
|
2006-03-24 |
2007-09-27 |
Barron Tenney |
Medical devices having nanoporous coatings for controlled therapeutic agent delivery
|
US8187620B2
(en)
*
|
2006-03-27 |
2012-05-29 |
Boston Scientific Scimed, Inc. |
Medical devices comprising a porous metal oxide or metal material and a polymer coating for delivering therapeutic agents
|
PL2019657T3
(pl)
|
2006-04-26 |
2015-10-30 |
Micell Technologies Inc |
Powłoki zawierające wiele leków
|
US20080051335A1
(en)
*
|
2006-05-02 |
2008-02-28 |
Kleiner Lothar W |
Methods, compositions and devices for treating lesioned sites using bioabsorbable carriers
|
US7868531B2
(en)
*
|
2006-05-05 |
2011-01-11 |
Brother International Corporation |
Carbon nanotube arrays for field electron emission
|
US20070264303A1
(en)
*
|
2006-05-12 |
2007-11-15 |
Liliana Atanasoska |
Coating for medical devices comprising an inorganic or ceramic oxide and a therapeutic agent
|
US8815275B2
(en)
|
2006-06-28 |
2014-08-26 |
Boston Scientific Scimed, Inc. |
Coatings for medical devices comprising a therapeutic agent and a metallic material
|
US20080004695A1
(en)
*
|
2006-06-28 |
2008-01-03 |
Abbott Cardiovascular Systems Inc. |
Everolimus/pimecrolimus-eluting implantable medical devices
|
JP2009542359A
(ja)
*
|
2006-06-29 |
2009-12-03 |
ボストン サイエンティフィック リミテッド |
選択的被覆部を備えた医療装置
|
US20080039362A1
(en)
*
|
2006-08-09 |
2008-02-14 |
Afmedica, Inc. |
Combination drug therapy for reducing scar tissue formation
|
US9173733B1
(en)
*
|
2006-08-21 |
2015-11-03 |
Abbott Cardiovascular Systems Inc. |
Tracheobronchial implantable medical device and methods of use
|
MX2009001857A
(es)
*
|
2006-08-22 |
2009-03-02 |
Novartis Ag |
Tratamiento de trastornos fibrosantes.
|
BRPI0715656A2
(pt)
*
|
2006-08-28 |
2013-07-02 |
Wyeth Corp |
sistemas de derivaÇço implantÁvel para drenar fluido de uma cavidade corporal, e de derivaÇço de fluido cerebrospinal, e, uso de um agente terapÊutico
|
EP2068757B1
(en)
|
2006-09-14 |
2011-05-11 |
Boston Scientific Limited |
Medical devices with drug-eluting coating
|
EP2084310A1
(en)
*
|
2006-10-05 |
2009-08-05 |
Boston Scientific Limited |
Polymer-free coatings for medical devices formed by plasma electrolytic deposition
|
US9539593B2
(en)
*
|
2006-10-23 |
2017-01-10 |
Micell Technologies, Inc. |
Holder for electrically charging a substrate during coating
|
US7981150B2
(en)
|
2006-11-09 |
2011-07-19 |
Boston Scientific Scimed, Inc. |
Endoprosthesis with coatings
|
CA2669415A1
(en)
*
|
2006-11-14 |
2008-05-22 |
Ariad Pharmaceuticals, Inc. |
Solid dosage form comprising ap23573
|
US7713541B1
(en)
|
2006-11-21 |
2010-05-11 |
Abbott Cardiovascular Systems Inc. |
Zwitterionic terpolymers, method of making and use on medical devices
|
CA2679712C
(en)
|
2007-01-08 |
2016-11-15 |
Micell Technologies, Inc. |
Stents having biodegradable layers
|
US11426494B2
(en)
|
2007-01-08 |
2022-08-30 |
MT Acquisition Holdings LLC |
Stents having biodegradable layers
|
EP2125895B1
(en)
|
2007-02-02 |
2015-04-08 |
Vegenics Pty Ltd |
Vegf receptor antagonists for treating organ transplant alloimmunity and arteriosclerosis
|
US8070797B2
(en)
|
2007-03-01 |
2011-12-06 |
Boston Scientific Scimed, Inc. |
Medical device with a porous surface for delivery of a therapeutic agent
|
US8431149B2
(en)
|
2007-03-01 |
2013-04-30 |
Boston Scientific Scimed, Inc. |
Coated medical devices for abluminal drug delivery
|
US20080241215A1
(en)
*
|
2007-03-28 |
2008-10-02 |
Robert Falotico |
Local vascular delivery of probucol alone or in combination with sirolimus to treat restenosis, vulnerable plaque, aaa and stroke
|
US8067054B2
(en)
|
2007-04-05 |
2011-11-29 |
Boston Scientific Scimed, Inc. |
Stents with ceramic drug reservoir layer and methods of making and using the same
|
KR101158981B1
(ko)
*
|
2007-04-17 |
2012-06-21 |
미셀 테크놀로지즈, 인코포레이티드 |
생체분해성 층을 갖는 스텐트
|
US7976915B2
(en)
*
|
2007-05-23 |
2011-07-12 |
Boston Scientific Scimed, Inc. |
Endoprosthesis with select ceramic morphology
|
JP2010527746A
(ja)
*
|
2007-05-25 |
2010-08-19 |
ミセル テクノロジーズ、インコーポレイテッド |
メディカルデバイスコーティング用ポリマーフィルム
|
US7942926B2
(en)
*
|
2007-07-11 |
2011-05-17 |
Boston Scientific Scimed, Inc. |
Endoprosthesis coating
|
US8002823B2
(en)
*
|
2007-07-11 |
2011-08-23 |
Boston Scientific Scimed, Inc. |
Endoprosthesis coating
|
EP2187988B1
(en)
|
2007-07-19 |
2013-08-21 |
Boston Scientific Limited |
Endoprosthesis having a non-fouling surface
|
US7931683B2
(en)
|
2007-07-27 |
2011-04-26 |
Boston Scientific Scimed, Inc. |
Articles having ceramic coated surfaces
|
US8815273B2
(en)
*
|
2007-07-27 |
2014-08-26 |
Boston Scientific Scimed, Inc. |
Drug eluting medical devices having porous layers
|
CA2693338A1
(en)
*
|
2007-07-31 |
2009-02-05 |
Limerick Biopharma, Inc. |
Phosphorylated pyrone analogs and methods
|
WO2009018340A2
(en)
*
|
2007-07-31 |
2009-02-05 |
Boston Scientific Scimed, Inc. |
Medical device coating by laser cladding
|
JP2010535541A
(ja)
*
|
2007-08-03 |
2010-11-25 |
ボストン サイエンティフィック リミテッド |
広い表面積を有する医療器具用のコーティング
|
US20090104240A1
(en)
*
|
2007-10-19 |
2009-04-23 |
Abbott Cardiovascular Systems Inc. |
Dual Drug Formulations For Implantable Medical Devices For Treatment of Vascular Diseases
|
WO2009051780A1
(en)
*
|
2007-10-19 |
2009-04-23 |
Micell Technologies, Inc. |
Drug coated stents
|
US20090118809A1
(en)
*
|
2007-11-02 |
2009-05-07 |
Torsten Scheuermann |
Endoprosthesis with porous reservoir and non-polymer diffusion layer
|
US7938855B2
(en)
*
|
2007-11-02 |
2011-05-10 |
Boston Scientific Scimed, Inc. |
Deformable underlayer for stent
|
US8029554B2
(en)
*
|
2007-11-02 |
2011-10-04 |
Boston Scientific Scimed, Inc. |
Stent with embedded material
|
US20090118818A1
(en)
*
|
2007-11-02 |
2009-05-07 |
Boston Scientific Scimed, Inc. |
Endoprosthesis with coating
|
US8216632B2
(en)
|
2007-11-02 |
2012-07-10 |
Boston Scientific Scimed, Inc. |
Endoprosthesis coating
|
US20090155337A1
(en)
*
|
2007-11-12 |
2009-06-18 |
Endologix, Inc. |
Method and agent for in-situ stabilization of vascular tissue
|
US20090214654A1
(en)
*
|
2008-02-21 |
2009-08-27 |
Isenburg Jason C |
Treatment of aneurysm with application of connective tissue stabilization agent in combination with a delivery vehicle
|
US8409601B2
(en)
|
2008-03-31 |
2013-04-02 |
Cordis Corporation |
Rapamycin coated expandable devices
|
US8420110B2
(en)
|
2008-03-31 |
2013-04-16 |
Cordis Corporation |
Drug coated expandable devices
|
CN102083397B
(zh)
*
|
2008-04-17 |
2013-12-25 |
米歇尔技术公司 |
具有生物可吸收层的支架
|
WO2009131911A2
(en)
|
2008-04-22 |
2009-10-29 |
Boston Scientific Scimed, Inc. |
Medical devices having a coating of inorganic material
|
WO2009132176A2
(en)
|
2008-04-24 |
2009-10-29 |
Boston Scientific Scimed, Inc. |
Medical devices having inorganic particle layers
|
EP2303350A2
(en)
|
2008-06-18 |
2011-04-06 |
Boston Scientific Scimed, Inc. |
Endoprosthesis coating
|
WO2009158031A2
(en)
*
|
2008-06-27 |
2009-12-30 |
Limerick Biopharma, Inc. |
Methods and compositions for therapeutic treatment
|
US20100016833A1
(en)
*
|
2008-07-15 |
2010-01-21 |
Ogle Matthew F |
Devices for the Treatment of Vascular Aneurysm
|
US9486431B2
(en)
*
|
2008-07-17 |
2016-11-08 |
Micell Technologies, Inc. |
Drug delivery medical device
|
KR20110074758A
(ko)
*
|
2008-10-03 |
2011-07-01 |
엘릭서 메디컬 코포레이션 |
마크로사이클릭 락톤 화합물 및 이를 사용하는 방법
|
US20100119605A1
(en)
*
|
2008-11-12 |
2010-05-13 |
Isenburg Jason C |
Compositions for tissue stabilization
|
US8231980B2
(en)
*
|
2008-12-03 |
2012-07-31 |
Boston Scientific Scimed, Inc. |
Medical implants including iridium oxide
|
US8834913B2
(en)
*
|
2008-12-26 |
2014-09-16 |
Battelle Memorial Institute |
Medical implants and methods of making medical implants
|
US8071156B2
(en)
*
|
2009-03-04 |
2011-12-06 |
Boston Scientific Scimed, Inc. |
Endoprostheses
|
US20100256746A1
(en)
*
|
2009-03-23 |
2010-10-07 |
Micell Technologies, Inc. |
Biodegradable polymers
|
US20100241220A1
(en)
*
|
2009-03-23 |
2010-09-23 |
Mcclain James B |
Peripheral Stents Having Layers
|
US9981072B2
(en)
*
|
2009-04-01 |
2018-05-29 |
Micell Technologies, Inc. |
Coated stents
|
WO2010121187A2
(en)
|
2009-04-17 |
2010-10-21 |
Micell Techologies, Inc. |
Stents having controlled elution
|
US20100274352A1
(en)
*
|
2009-04-24 |
2010-10-28 |
Boston Scientific Scrimed, Inc. |
Endoprosthesis with Selective Drug Coatings
|
US8287937B2
(en)
*
|
2009-04-24 |
2012-10-16 |
Boston Scientific Scimed, Inc. |
Endoprosthese
|
EP2453834A4
(en)
|
2009-07-16 |
2014-04-16 |
Micell Technologies Inc |
MEDICAL DEVICE DISPENSING MEDICINE
|
US8496911B2
(en)
*
|
2009-07-29 |
2013-07-30 |
Vatrix CHF, Inc. |
Tissue stabilization for heart failure
|
US20110218517A1
(en)
*
|
2009-10-09 |
2011-09-08 |
Ogle Matthew F |
In vivo chemical stabilization of vulnerable plaque
|
US8444624B2
(en)
|
2009-10-19 |
2013-05-21 |
Vatrix Medical, Inc. |
Vascular medical devices with sealing elements and procedures for the treatment of isolated vessel sections
|
US8951595B2
(en)
*
|
2009-12-11 |
2015-02-10 |
Abbott Cardiovascular Systems Inc. |
Coatings with tunable molecular architecture for drug-coated balloon
|
US8480620B2
(en)
*
|
2009-12-11 |
2013-07-09 |
Abbott Cardiovascular Systems Inc. |
Coatings with tunable solubility profile for drug-coated balloon
|
US20110144577A1
(en)
*
|
2009-12-11 |
2011-06-16 |
John Stankus |
Hydrophilic coatings with tunable composition for drug coated balloon
|
EP2531140B1
(en)
*
|
2010-02-02 |
2017-11-01 |
Micell Technologies, Inc. |
Stent and stent delivery system with improved deliverability
|
US8795762B2
(en)
*
|
2010-03-26 |
2014-08-05 |
Battelle Memorial Institute |
System and method for enhanced electrostatic deposition and surface coatings
|
EP2558026A4
(en)
*
|
2010-04-16 |
2013-10-23 |
Micell Technologies Inc |
STENTS WITH TAXED ELUTION
|
US10232092B2
(en)
|
2010-04-22 |
2019-03-19 |
Micell Technologies, Inc. |
Stents and other devices having extracellular matrix coating
|
CA2805631C
(en)
|
2010-07-16 |
2018-07-31 |
Micell Technologies, Inc. |
Drug delivery medical device
|
WO2012034079A2
(en)
|
2010-09-09 |
2012-03-15 |
Micell Technologies, Inc. |
Macrolide dosage forms
|
WO2012047813A1
(en)
*
|
2010-10-04 |
2012-04-12 |
Elixir Medical Corporation |
Macrocyclic lactone compounds and methods for their use
|
US8911468B2
(en)
|
2011-01-31 |
2014-12-16 |
Vatrix Medical, Inc. |
Devices, therapeutic compositions and corresponding percutaneous treatment methods for aortic dissection
|
WO2012158944A1
(en)
|
2011-05-18 |
2012-11-22 |
Vatrix Medical, Inc. |
Coated balloons for blood vessel stabilization
|
US10464100B2
(en)
|
2011-05-31 |
2019-11-05 |
Micell Technologies, Inc. |
System and process for formation of a time-released, drug-eluting transferable coating
|
US10117972B2
(en)
|
2011-07-15 |
2018-11-06 |
Micell Technologies, Inc. |
Drug delivery medical device
|
US9220716B2
(en)
*
|
2011-07-26 |
2015-12-29 |
Children's Medical Center Corporation |
Methods and compositions for the treatment of proliferative vascular disorders
|
US10188772B2
(en)
|
2011-10-18 |
2019-01-29 |
Micell Technologies, Inc. |
Drug delivery medical device
|
US20140094900A1
(en)
*
|
2012-10-01 |
2014-04-03 |
Brigham Young University |
Compliant biocompatible device and method of manufacture
|
EP2967803B1
(en)
|
2013-03-12 |
2023-12-27 |
Micell Technologies, Inc. |
Bioabsorbable biomedical implants
|
WO2014160358A1
(en)
*
|
2013-03-14 |
2014-10-02 |
Thomas Cooper Woods |
Use of mir-221 and 222 lowering agents to prevent cardiovascular disease in diabetic subjects
|
US9522130B2
(en)
|
2013-03-14 |
2016-12-20 |
Thomas Cooper Woods |
Use of miR-221 and 222 lowering agents to prevent cardiovascular disease in diabetic subjects
|
EP2994758B1
(en)
|
2013-05-08 |
2017-12-20 |
Opthea Limited |
Biomarkers for age-related macular degeneration (amd)
|
WO2014186532A1
(en)
|
2013-05-15 |
2014-11-20 |
Micell Technologies, Inc. |
Bioabsorbable biomedical implants
|
WO2016100782A1
(en)
*
|
2014-12-18 |
2016-06-23 |
University Of South Carolina |
Suppression of neointimal formation following vascular surgery using cdk8 inhibitors
|
KR20190056401A
(ko)
|
2016-09-22 |
2019-05-24 |
머케이터 메드시스템즈, 인크. |
템시롤리무스를 사용하는 재협착의 치료
|
US10576063B2
(en)
|
2017-05-26 |
2020-03-03 |
Mercator Medsystems, Inc. |
Combination therapy for treatment of restenosis
|
CN109010931B
(zh)
*
|
2017-06-09 |
2022-03-11 |
上海微创医疗器械(集团)有限公司 |
介入医疗器械及阿非迪霉素的应用
|
WO2019104065A1
(en)
*
|
2017-11-22 |
2019-05-31 |
Turrinii Pharmaceutical, Llc |
Anti-aging methods and compositions
|
US11654267B2
(en)
|
2018-03-14 |
2023-05-23 |
Mercator Medsystems, Inc. |
Medical instrument and medical method for localized drug delivery
|
CA3107349A1
(en)
|
2018-07-23 |
2020-01-30 |
Enclear Therapies, Inc. |
Methods of treating neurological disorders
|
WO2020023418A1
(en)
|
2018-07-23 |
2020-01-30 |
Enclear Therapies, Inc. |
Methods of treating neurological disorders
|
EP3952947A4
(en)
|
2019-04-11 |
2024-07-03 |
Enclear Therapies Inc |
METHODS FOR IMPROVING CEREBRAL SPINAL FLUID AND DEVICES AND SYSTEMS THEREFOR
|